课题基金 / 基金详情

Investigating Medication Errors in Daily Life: Discovering Person-specific and Situation-specific Risk Factors

Investigating Medication Errors in Daily Life: Discovering Person-specific and Situation-specific Risk Factors
调查日常生活中的用药错误:发现特定于个人和特定情况的风险因素
批准号:
10202481
负责人:
Nelson Roque
金额:
$7.45万
依托单位国家:
美国
项目类别:
财政年份:
2020
资助国家:
美国
项目状态:
已结题
起止时间:
2020-07-01 至 2024-05-31

项目摘要

项目成果

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
PROJECT SUMMARY/ABSTRACT In order to maintain independence into late adulthood, one must be able to safely and reliably participate in Instrumental Activities of Daily Living (IADLs), including taking medications for treatment of chronic conditions. The potential to do this safely without making a medication error depends on a multitude of pre-conditions, including: the number of distinct medications consumed, cognitive status (e.g., dementia), the presence of a caregiver or other mental scaffolds (i.e., medication diary), and cognitive vulnerability (e.g., susceptibility to distraction). Medication errors are numerous — over a million yearly injuries and 98,000 deaths — and occur across the spectrum of healthcare (i.e., nurses, physicians, pharmacists, patients), yet little is known about medication errors in daily life. For this R03, we are specifically interested in understanding the types of medication errors made in daily life, and discovering person-specific and situation-specific risk factors for medication errors in the home. Perceptions of medication administration problems, medication regimen complexity, and the nature of medication errors in the home and their consequences will be assessed in older adults currently recruited into the Einstein Aging Study (EAS), using an innovative three-pronged medication assessment (i.e., daily EMA of medication administration problems, medication error history interview with study neurologist, medication possession ratios from EHRs). Making use of existing clinical data (i.e., ratings of MCI), and cognitive performance data (both in-lab and ambulatory assessments) we will identify person-specific and situation-specific risk factors for various types of medication errors. Completion of this work will highlight actionable targets for future interventions targeting the reduction of medication errors.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
国内基金
海外基金
补阳还五汤通过AGE-RAGE通路调控脓毒症免疫失衡的机制与转化研究
靶向递送一氧化碳调控AGE-RAGE级联反应促进糖尿病创面愈合研究
  • 批准号:
    JCZRQN202500010
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
  • 依托单位:
对香豆酸抑制AGE-RAGE-Ang-1通路改善海马血管生成障碍发挥抗阿尔兹海默病作用
  • 批准号:
    2025JJ70209
  • 项目类别:
    省市级项目
  • 资助金额:
    --
  • 批准年份:
    2025
  • 负责人:
    雷芬芳
  • 依托单位:
AGE-RAGE通路调控慢性胰腺炎纤维化进程的作用及分子机制
  • 批准号:
    --
  • 项目类别:
    面上项目
  • 资助金额:
    --
  • 批准年份:
    2024
  • 负责人:
    万荣
  • 依托单位: